NOTCH1 and small cell lung carcinoma: Last, we sought to determine the prevalence of active NOTCH1 signaling in SCLC and assess for the potential utility of NOTCH1 as a clinical biomarker through IHC staining of the intracellular domain (ICD) of NOTCH1 in SCLC preclinical models and patient tissues.